| 000 | 02599 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250515224104.0 | ||
| 264 | 0 | _c20100827 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/j.1365-2249.2010.04167.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeraviglia, S | |
| 245 | 0 | 0 |
_aIn vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cAug 2010 |
||
| 300 |
_a290-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadverse effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChemokines _xblood |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEsterases _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemiterpenes _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-2 _xadverse effects |
| 650 | 0 | 4 |
_aLeukocyte Common Antigens _xmetabolism |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMucin-1 _xblood |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, gamma-delta _xmetabolism |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xcytology |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor Receptor Superfamily, Member 7 _xmetabolism |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aEberl, M | |
| 700 | 1 | _aVermijlen, D | |
| 700 | 1 | _aTodaro, M | |
| 700 | 1 | _aBuccheri, S | |
| 700 | 1 | _aCicero, G | |
| 700 | 1 | _aLa Mendola, C | |
| 700 | 1 | _aGuggino, G | |
| 700 | 1 | _aD'Asaro, M | |
| 700 | 1 | _aOrlando, V | |
| 700 | 1 | _aScarpa, F | |
| 700 | 1 | _aRoberts, A | |
| 700 | 1 | _aCaccamo, N | |
| 700 | 1 | _aStassi, G | |
| 700 | 1 | _aDieli, F | |
| 700 | 1 | _aHayday, A C | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 161 _gno. 2 _gp. 290-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2010.04167.x _zAvailable from publisher's website |
| 999 |
_c19844963 _d19844963 |
||